NewEdge Advisors’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $1.42K | Hold |
|
|||||
|
2024
Q4 | $1.85K | Buy |
|
|||||
|
2024
Q3 | $1.5K | Hold |
|
|||||
|
2024
Q2 | $1.35K | Hold |
|
|||||
|
2024
Q1 | $1.66K | Hold |
|
|||||
|
2023
Q4 | $1.35K | Hold |
|
|||||
|
2023
Q3 | $1.1K | Buy |
|
|||||
|
2023
Q2 | $129 | Hold |
|
|||||
|
2023
Q1 | $120 | Hold |
|
|||||
|
2022
Q4 | $0 | Buy |
|